Utilization and Outcomes of Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement (TAVR)

Utilization and Outcomes of Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement (TAVR)

Saved in:

Bibliographic Details
Main Authors:	Agam Bansal, Grant W. Reed, Rishi Puri, James Yun, Amar Krishnaswamy, Samir R. Kapadia
Format:	Article
Language:	English
Published:	Wiley 2025-05-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	dual antiplatelet therapy single antiplatelet therapy TAVR
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.124.038297
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Antithrombotic strategies after transcatheter aortic valve replacement a network meta-analysis
by: Mengxiao Shi, et al.
Published: (2025-05-01)

Outcomes and Predictors of Stroke After Transcatheter Aortic Valve Replacement in the Cerebral Protection Device Era
by: Shashank Shekhar, et al.
Published: (2024-08-01)

Does preoperative antiplatelet therapy worsen outcomes in acute type A aortic dissection surgery? A meta-analytic review
by: Kristine Santos, et al.
Published: (2025-07-01)

PHARMACOGENETIC BASES OF INDIVIDUAL SENSITIVITY AND PERSONALIZED ADMINISTRATION OF ANTIPLATELET THERAPY IN DIFFERENT ETHNIC GROUPS
by: B. I. Kantemirova, et al.
Published: (2021-05-01)

UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

Dual Antiplatelet Therapy Regimens and Duration for Intracranial Stenting Procedures: Literature Review
by: Milda Paliulytė, et al.
Published: (2023-11-01)

Initial experience with transcatheter aortic valve replacement before and after lung transplantCentral MessagePerspective
by: Mujtaba Mubashir, MD, et al.
Published: (2024-11-01)

THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS
by: O. V. Gaisenok
Published: (2016-01-01)

Timing of dual antiplatelet therapy in acute coronary syndrome: a problem of coronary artery bypass grafting accessibility for patients
by: T. S. Golovina, et al.
Published: (2020-09-01)

Rationale and Design of the CREATE Trial: A Multicenter, Randomized Comparison of Continuation or Cessation of Single Antithrombotic Therapy at 1 Year After Transcatheter Aortic Valve Replacement
by: Ran Liu, et al.
Published: (2025-04-01)

Antiplatelet Therapy in Acute Coronary Syndrome
by: I. M. Kuzmina, et al.
Published: (2022-01-01)

The role of antiplatelet therapy on arteriovenous fistula malfunctioning among hemodialysis patients
by: Moayad Abdullah Wahab, et al.
Published: (2023-12-01)

Novel transcatheter aortic valve replacement devicesCentral MessagePerspective
by: Ankur Sethi, MBBS, FACC, et al.
Published: (2025-03-01)

Catheter replacement combined with antiplatelet therapy in hemodialysis catheter-related right atrial thrombus: a potential treatment approach
by: Jibo Sun, et al.
Published: (2025-01-01)

PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW
by: I. S. Yavelov
Published: (2017-09-01)

CONTEMPORARY APPROACHES TO ANTIPLATELET THERAPY IN CORONARY HEART DISEASE TREATMENT
by: S. T. Matskeplishvili, et al.
Published: (2014-08-01)

ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS?
by: Yu. I. Grinshtein, et al.
Published: (2015-09-01)

Antiplatelet Therapy in Myocardial Bridge: Insights From the RIALTO Registry
by: Renzo Laborante, et al.
Published: (2025-07-01)

ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

Efficacy of Platelet Rich Fibrin versus chitosan as a hemostatic agent following dental extraction in patients on antiplatelet therapy
by: Sourav Sarkar, et al.
Published: (2019-10-01)

DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE
by: G. N. Guseva, et al.
Published: (2015-09-01)

Dual antiplatelet therapy in patients with acute coronary syndrome. Results of actual clinical practice
by: O. L. Barbarash, et al.
Published: (2018-11-01)

DURATION OF DUAL ANTIPLATELET THERAPY
by: O. L. Barbarash
Published: (2016-07-01)

Impact of antiplatelet therapy on hemostatic plug formation in the setting of thrombocytopenia
by: Robert H. Lee, et al.
Published: (2025-01-01)

Progress Analysis of Personalized Antiplatelet Therapy in Patients with Coronary Heart Disease Undergoing Interventional Therapy
by: Ji-tong Yang, et al.
Published: (2024-12-01)

TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS
by: O. L. Barbarash, et al.
Published: (2016-02-01)

MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: N. F. Puchinian, et al.
Published: (2017-03-01)

The study of price situation on the domestic antiplatelet market
by: Ye. А. Redkina, et al.
Published: (2017-08-01)

Tirofiban Combination Therapy for Acute Ischemic Stroke: A Systematic Review and Meta‐Analysis
by: Abdullah Bin Kamran, et al.
Published: (2025-06-01)

Antiplatelet Use Prior to Anticoagulant Initiation in Patients With Atrial Fibrillation-Related Ischemic Stroke: An ELAN Trial Analysis
by: Alexandros A. Polymeris, et al.
Published: (2025-05-01)

Antiplatelet Therapy in Heart Disease
by: Nil Ozyuncu
Published: (2025-06-01)

Persistent risk of vascular complications and efficacy of prolonged dual antiplatelet therapy after myocardial infarction
by: I. S. Yavelo
Published: (2022-01-01)

Navigating the Therapeutic Dilemma: Safety and Efficacy of Antiplatelet, Anticoagulation and Statin Therapy in Dengue Hemorrhagic Fever, a Case-Based Literature Review
by: N. M. M. Risly, et al.
Published: (2025-01-01)

Redo Aortic Valve Replacement After Prior Transcatheter versus Surgical Aortic Valve Replacement: Insights from Western Experience
by: Arber Aliu, et al.
Published: (2025-01-01)

Impact of health education on adherence to clopidogrel and clinical effectiveness of antiplatelet treatment in patients after myocardial infarction
by: Aldona Kubica, et al.
Published: (2015-12-01)

The impact of platelets and antiplatelets medications on immune mediation
by: Leela Morena, MD, et al.
Published: (2025-01-01)

ТHE ROLE OF GENETIC TESTING FOR OPTIMAL ANTIPLATELET THERAPY SELECTION IN THE TREATMENT OF CORONARY ARTERY DISEASE PATIENTS
by: S. T. Matskeplishvili, et al.
Published: (2014-04-01)

Efficiency and safety of various dual antiplatelet therapy strategies in patients undergoing percutaneous coronary intervention due to myocardial infarction
by: S. B. Aksentiev, et al.
Published: (2021-08-01)

ANTIPLATELET THERAPY IN THE PREVENTION OF CEREBROVASCULAR ACCIDENTS
by: O. V. Rodionova, et al.
Published: (2017-03-01)

ACC/AHA CLOPIDOGREL CLINICAL ALERT. WHAT MUST BE MODERN ANTIPLATELET THERAPY?
by: S. J. Martsevich
Published: (2016-01-01)